Acadia Pharmaceutica (ACAD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 441,755 | 339,076 | 223,807 | 124,901 | 17,331 |
| Cost of Goods | 10,211 | 11,344 | 12,377 | 9,077 | 3,075 |
| Gross Profit | 431,544 | 327,732 | 211,430 | 115,824 | 14,256 |
| Operating Expenses | 718,341 | 574,621 | 459,251 | 408,311 | 287,146 |
| Operating Income | -286,586 | -246,545 | -247,444 | -292,410 | -272,815 |
| Other Income | 5,613 | 12,162 | 3,508 | 4,126 | 2,763 |
| Pre-tax Income | -280,973 | -234,383 | -243,936 | -288,284 | -270,052 |
| Income Tax | 611 | 876 | 1,256 | 1,119 | 1,341 |
| Net Income Continuous | -281,584 | -235,259 | -245,192 | -289,403 | -271,393 |
| Net Income | $-281,584 | $-235,259 | $-245,192 | $-289,403 | $-271,393 |
| EPS Basic Total Ops | -1.79 | -1.60 | -1.94 | -2.36 | -2.34 |
| EPS Basic Continuous Ops | -1.79 | -1.60 | -1.94 | -2.36 | -2.34 |
| EPS Diluted Total Ops | -1.79 | -1.60 | -1.94 | -2.36 | -2.34 |
| EPS Diluted Continuous Ops | -1.79 | -1.60 | -1.94 | -2.36 | -2.34 |
| EPS Diluted Before Non-Recurring Items | -1.79 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-282,184 | $-247,392 | $-245,017 | $-289,988 | $-270,898 |